Table 3.

Outcome measures according to specific combination anti-thrombotic therapy

Combination therapy	Cases (n)	Indication for combination therapy	Average length of hospital stay	Number of patients requiring nasal packing	Patients requiring re-admission
Aspirin & clopidogrel	8	Secondary cardiovascular prevention	2.5	6	2
Warfarin, aspirin & clopidogrel	1	Mechanical heart valve	1.0	1	0
Warfarin & clopidogrel	2	Metallic mitral valve & post-PCI	1.5	1	0
Ticagrelor & aspirin	1	Post-ACS	0	0	0
Apixaban, aspirin & ticagrelor	2	Post-ACS	2.5	1	2

PCI primary coronary intervention

ACS acute coronary syndrome